Dermveda ULTRA BITE ITCH RELIEF NDC 83819-106

NDC codes

FDA NDC Directory

Product NDC (as listed)83819-106Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83819-0106Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
83819-106-02	83819010602	60 mL in 1 JAR (83819-106-02)Marketed from Sep 18, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dermveda ULTRA BITE ITCH RELIEF
Generic name (nonproprietary): mentha piperita, curcuma longa
Active ingredients: Mentha x piperita whole — 10 [hp_X]/60mLTurmeric — 10 [hp_C]/60mL
Dosage form: Cream
Route: Topical
Labeler: Celcius Corp.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Sep 18, 2024
Listing expires: Dec 31, 2027
Identifiers: Product ID 83819-106_f0ecbd75-2453-42c5-9ca7-03a3a6fabe65SPL ID f0ecbd75-2453-42c5-9ca7-03a3a6fabe65SPL set ID 232c344e-184d-4c95-bc2c-97c4c9cab091UNII 79M2M2UDA9, 856YO1Z64FUPC 0198168226766

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N483819010602 followed by a unit qualifier and the quantity

Package 83819-0106-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 16, 2026.

Indications (excerpt from the label)

Uses • Ask your Physician before using this for self-treatment. Provides temporary relief from Skin Inflammation, Irritation and/or tingling caused.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)